These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36894259)

  • 21. Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry.
    Bikov A; Paschalaki K; Logan-Sinclair R; Horváth I; Kharitonov SA; Barnes PJ; Usmani OS; Paredi P
    BMC Pulm Med; 2013 Jul; 13():43. PubMed ID: 23837867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observation of nonanoic acid and aldehydes in exhaled breath of patients with lung cancer.
    Callol-Sanchez L; Munoz-Lucas MA; Gomez-Martin O; Maldonado-Sanz JA; Civera-Tejuca C; Gutierrez-Ortega C; Rodriguez-Trigo G; Jareno-Esteban J
    J Breath Res; 2017 Apr; 11(2):026004. PubMed ID: 28440225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensors for detecting pulmonary diseases from exhaled breath.
    Hashoul D; Haick H
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation.
    Wang C; Dong R; Wang X; Lian A; Chi C; Ke C; Guo L; Liu S; Zhao W; Xu G; Li E
    Sci Rep; 2014 Dec; 4():7312. PubMed ID: 25482491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.
    Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchoscopically obtained volatile biomarkers in lung cancer.
    Darwiche K; Baumbach JI; Sommerwerck U; Teschler H; Freitag L
    Lung; 2011 Dec; 189(6):445-52. PubMed ID: 21968685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhaled breath analysis by electronic nose in respiratory diseases.
    Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
    Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point-of-Care Test Paper for Exhaled Breath Aldehyde Analysis via Mass Spectrometry.
    Li Z; Li Y; Zhan L; Meng L; Huang X; Wang T; Li Y; Nie Z
    Anal Chem; 2021 Jul; 93(26):9158-9165. PubMed ID: 34162204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Searching for selected VOCs in human breath samples as potential markers of lung cancer.
    Rudnicka J; Kowalkowski T; Buszewski B
    Lung Cancer; 2019 Sep; 135():123-129. PubMed ID: 31446984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data Pre-Processing of Infrared Spectral Breathprints for Lung Cancer Detection.
    Larracy R; Phinyomark A; Scheme E
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1353-1357. PubMed ID: 34891535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing lung cancer in exhaled breath using gold nanoparticles.
    Peng G; Tisch U; Adams O; Hakim M; Shehada N; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Haick H
    Nat Nanotechnol; 2009 Oct; 4(10):669-73. PubMed ID: 19809459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volatile Organic Compounds in Human Breath.
    Karunagaran M; Ramani P; Gheena S; Abilasha R; Hannah R
    Indian J Dent Res; 2022; 33(1):100-104. PubMed ID: 35946254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alveolar air volatile organic compound extractor for clinical breath sampling.
    de Silva G; Beyette FR
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5369-72. PubMed ID: 25571207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
    Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
    Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.